FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Cue Health EUA for Mpox Molecular Test

Federal Register notice: FDA announces the issuance of an emergency use authorization to Cue Health for the Cue Mpox (Monkeypox) Molecular Test.

latest-news-card-1
Human Drugs

Panel Backs Rexulti for Alzheimers Agitation

A joint advisory committee meeting votes 9 to 1 that an Otsuka Pharmaceutical and Lundbeck a sNDA for Rexulti (brexpriprazole) provided sufficient dat...

latest-news-card-1
Medical Devices

FDA Clears Reader for FreeStyle Libre 3

FDA clears an Abbott 510(k) for a reader for its FreeStyle Libre 3 integrated continuous glucose monitoring system.

latest-news-card-1
Human Drugs

Avenue Therapeutics Plans IV Tramadol Resubmission

Avenue Therapeutics meets with FDA to map out a plan for resubmitting a twice-rejected NDA for intravenous tramadol for treating post-operative pain.

latest-news-card-1
Human Drugs

Complete Response on Lillys Ulcerative Colitis Drug

FDA sends Eli Lilly a complete response letter on its BLA for mirikizumab and its use for treating ulcerative colitis.

latest-news-card-1
Federal Register

Revised Draft Guide on Transdermal Drug Adhesives

Federal Register notice: FDA makes available a revised draft guidance Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs.

latest-news-card-1
Federal Register

PTA Catheter Submission Guidance

Federal Register notice: FDA makes available a final guidance entitled Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters ...

latest-news-card-1
Human Drugs

High Court Issues 5-day Stay in Abortion Drug Case

The Supreme Court grants a Department of Justice-requested temporary stay of a lower courts 4/7 order that would have restricted the distribution of t...

latest-news-card-1
Human Drugs

GOP Reps Challenge Generics from Alert Firms

Five House Republicans write FDA commissioner Robert Califf about agency safeguards in place when questionable foreign-made generic drugs are allowed ...

latest-news-card-1
Human Drugs

2nd Complete Response on Alvotech Humira Biosimilar

FDA sends Alvotech a second complete response letter on its BLA for AVT02, a biosimilar candidate referencing AbbVies Humira (adalimumab), based on ma...